EUVIMEDOdkrijte EUVIMED
Open access · CC BY-NC-ND 4.0

Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine

Marina Haro iD, Gabriel Gárate iD, José Luis Hernández iD, José Manuel Olmos iD, María Muñoz, Vicente González-Quintanilla iD, Julio Pascual iD

Headache: The Journal of Head and Face Pain · 2025

DOI: 10.1111/head.14901 ↗

At a glance

Journal article in Headache: The Journal of Head and Face Pain, 2025. Written by Marina Haro and 6 co-authors. Institution: Service of Internal Medicine, University Hospital Marqués de Valdecilla, Universidad de Cantabria and Valdecilla Research Institute (IDIVAL), Santand…. Major MEDLINE topics: Migraine Disorders, Vitamin D, Vitamin D Deficiency. Cited 2 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Instituto de Salud Carlos III (ISCIII), FEDER, Federación Española de Enfermedades Raras.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Serum 25‐hydroxyvitamin D (25[OH]D) concentrations have been shown to be low in patients with migraine, but results are controversial regarding the current role of vitamin D in migraine severity. Using a case–control design, we aimed to evaluate serum 25(OH)D levels in a group of females with high‐frequency episodic migraine/chronic migraine (HF/CM) and analyze its association with headache frequency and serum calcitonin gene–related peptide (CGRP) levels.

Methods

Serum 25(OH)D levels were measured in 97 females with HF/CM (age 48.9 ± 9.4 years) and 146 healthy females (47.4 ± 8.1 years). Participants taking vitamin D supplements were excluded. Serum concentrations of 25(OH)D were determined by electrochemiluminescence (Roche, Germany), and CGRP levels were measured by enzyme‐linked immunosorbent assay (Abbexa, UK).

Results

Mean 25(OH)D levels in females with HF/CM (median [interquartile range] 19.0 [13.0–24.5] ng/mL) were below the values considered for insufficiency or deficiency and significantly lower than controls (25.0 [19–29.8] ng/mL; p < 0.0001). Fifty (51.5%) patients with HF/CM had levels below 20 ng/mL. There was no significant association between vitamin D levels and monthly headache days (Spearman's rank correlation coefficient [rho]: −0.086; p = 0.404) or with serum α (rho: 0.114; p = 0.267) and β‐CGRP (rho: 0.113; p = 0.276) levels. Serum 25(OH)D levels in females with HF/CM with a minimum daily sunlight exposure were significantly higher than those without (23.0 [15.0–26.0] ng/mL vs. 14.0 [10.0–20.0] ng/mL; p < 0.001). Females with HF/CM who performed exercise had higher, albeit not significant, plasma 25(OH)D levels than those who did not (21.0 [15.5–28.0] ng/mL vs. 16.5 [12.0–24.0] ng/mL; p = 0.059).

Conclusions

Serum concentrations of 25(OH)D were low in many patients with HF/CM. Because there was no correlation with migraine frequency or serum CGRP levels, this deficiency seems to be a direct consequence of the migraine impact. Our data do not support either a relationship of 25(OH)D levels with migraine severity or the use of vitamin D supplements as a specific migraine treatment, although further studies are needed.

Subjects

MeSH terms (MEDLINE)

Migraine DisordersVitamin DVitamin D DeficiencyHumansFemaleMiddle AgedCase-Control StudiesAdultCalcitonin Gene-Related Peptide

Author keywords

25‐hydroxyvitamin Dcalcitonin gene–related peptidemigrainevitamin Dα‐calcitonin gene–related peptideβ‐calcitonin gene–related peptide

Substances

25-hydroxyvitamin DVitamin DCalcitonin Gene-Related Peptide

Authors and institutions

  • Service of Internal Medicine, University Hospital Marqués de Valdecilla, Universidad de Cantabria and Valdecilla Research Institute (IDIVAL), Santander, Spain.
  • Service of Neurology, University Hospital Marqués de Valdecilla, Universidad de Cantabria and Valdecilla Research Institute (IDIVAL), Santander, Spain.

ORCID profiles: Marina Haro, Gabriel Gárate, José Luis Hernández, José Manuel Olmos, Vicente González-Quintanilla, Julio Pascual

Funding

  • Instituto de Salud Carlos III (ISCIII)
  • FEDER
  • Federación Española de Enfermedades Raras

Cite

APA

Haro, M., Gárate, G., Hernández, J. L., Olmos, J. M., Muñoz, M., González-Quintanilla, V., & Pascual, J. (2025). Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14901

Vancouver

Haro M, Gárate G, Hernández JL, Olmos JM, Muñoz M, González-Quintanilla V, et al. Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.14901

BibTeX
@article{Haro2025,
  author = {Haro, Marina and Gárate, Gabriel and Hernández, José Luis and Olmos, José Manuel and Muñoz, María and González-Quintanilla, Vicente and Pascual, Julio},
  title = {Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2025},
  doi = {10.1111/head.14901}
}
Start for free →